BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 16499995)

  • 21. Methyl-CpG binding domain 1 gene polymorphisms and risk of primary lung cancer.
    Jang JS; Lee SJ; Choi JE; Cha SI; Lee EB; Park TI; Kim CH; Lee WK; Kam S; Choi JY; Kang YM; Park RW; Kim IS; Cho YL; Jung TH; Han SB; Park JY
    Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2474-80. PubMed ID: 16284366
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The functional polymorphism in the matrix metalloproteinase-7 promoter increases susceptibility to esophageal squamous cell carcinoma, gastric cardiac adenocarcinoma and non-small cell lung carcinoma.
    Zhang J; Jin X; Fang S; Wang R; Li Y; Wang N; Guo W; Wang Y; Wen D; Wei L; Dong Z; Kuang G
    Carcinogenesis; 2005 Oct; 26(10):1748-53. PubMed ID: 15930031
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The p53 codon 72 polymorphism and lung cancer risk.
    Fan R; Wu MT; Miller D; Wain JC; Kelsey KT; Wiencke JK; Christiani DC
    Cancer Epidemiol Biomarkers Prev; 2000 Oct; 9(10):1037-42. PubMed ID: 11045785
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of p53 genetic polymorphism (Arg72Pro) with estrogen receptor positive breast cancer risk in Japanese women.
    Noma C; Miyoshi Y; Taguchi T; Tamaki Y; Noguchi S
    Cancer Lett; 2004 Jul; 210(2):197-203. PubMed ID: 15183535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of the p53 codon 72 and intron 3 polymorphisms on non-small cell lung cancer (NSCLC) prognosis.
    Boldrini L; Gisfredi S; Ursino S; Lucchi M; Greco G; Mussi A; Donati V; Fontanini G
    Cancer Invest; 2008 Mar; 26(2):168-72. PubMed ID: 18259947
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between the risk for lung adenocarcinoma and a (-4) G-to-A polymorphism in the XPA gene.
    Butkiewicz D; Popanda O; Risch A; Edler L; Dienemann H; Schulz V; Kayser K; Drings P; Bartsch H; Schmezer P
    Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2242-6. PubMed ID: 15598786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Analysis of prognostic value of TP53 gene mutations in non-small cell lung cancer].
    Szymanowska A; Jassem E; Dziadziuszko R; Skrzypski M; Kobierska-Gulida G; Holm K; Borg A; Rzyman W; Limon J; Jassem J
    Pneumonol Alergol Pol; 2005; 73(3):264-9. PubMed ID: 16989164
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyclin D1 (CCND1) A870G gene polymorphism modulates smoking-induced lung cancer risk and response to platinum-based chemotherapy in non-small cell lung cancer (NSCLC) patients.
    Gautschi O; Hugli B; Ziegler A; Bigosch C; Bowers NL; Ratschiller D; Jermann M; Stahel RA; Heighway J; Betticher DC
    Lung Cancer; 2006 Mar; 51(3):303-11. PubMed ID: 16406195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The TP53 Arg72Pro polymorphism and lung cancer risk in a population of Northern Spain.
    Fernández-Rubio A; López-Cima MF; González-Arriaga P; García-Castro L; Pascual T; Marrón MG; Tardón A
    Lung Cancer; 2008 Sep; 61(3):309-16. PubMed ID: 18336951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CYP1A1 Ile462Val and MPO G-463A interact to increase risk of adenocarcinoma but not squamous cell carcinoma of the lung.
    Larsen JE; Colosimo ML; Yang IA; Bowman R; Zimmerman PV; Fong KM
    Carcinogenesis; 2006 Mar; 27(3):525-32. PubMed ID: 16195240
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [TP53 codon 72 polymorphism and gastric cancer risk: a case-control study in individuals from the central-western region of Venezuela].
    Cañas M; Morán Y; Camargo ME; Rivero MB; Bohórquez A; Villegas V; Ramírez E; Rendón Y; Suárez A; Morales L; Useche E; Salazar S; Zambrano A; Ramírez A; Valderrama E; Briceño Z; Chiurillo MA
    Invest Clin; 2009 Jun; 50(2):153-61. PubMed ID: 19662811
    [TBL] [Abstract][Full Text] [Related]  

  • 32. p53 codon 72 polymorphism in Taiwanese lung cancer patients: association with lung cancer susceptibility and prognosis.
    Wang YC; Chen CY; Chen SK; Chang YY; Lin P
    Clin Cancer Res; 1999 Jan; 5(1):129-34. PubMed ID: 9918210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The TP53 codon 72 polymorphism and predisposition to adrenocortical cancer in Polish patients.
    Ignaszak-Szczepaniak M; Horst-Sikorska W; Sawicka J; Kaczmarek M; Slomski R
    Oncol Rep; 2006 Jul; 16(1):65-71. PubMed ID: 16786124
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of EcoRI polymorphism of the metastasis-suppressor gene NME1 with susceptibility to and severity of non-small cell lung cancer.
    Hsieh YS; Lee YL; Yang SF; Yang JS; Chen W; Chen SC; Shih CM
    Lung Cancer; 2007 Nov; 58(2):191-5. PubMed ID: 17688968
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Topoisomerase IIalpha gene expression is regulated by the p53 tumor suppressor gene in nonsmall cell lung carcinoma patients.
    Liu D; Huang CL; Kameyama K; Hayashi E; Yamauchi A; Sumitomo S; Yokomise H
    Cancer; 2002 Apr; 94(8):2239-47. PubMed ID: 12001123
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of TP53 codon 72 polymorphism with cervical cancer risk in Chinese women.
    Jiang P; Liu J; Zeng X; Li W; Tang J
    Cancer Genet Cytogenet; 2010 Mar; 197(2):174-8. PubMed ID: 20193851
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The associations of p53 overexpression with p53 codon 72 genetic polymorphism in esophageal cancer.
    Lee JM; Shun CT; Wu MT; Chen YY; Yang SY; Hung HI; Chen JS; Hsu HH; Huang PM; Kuo SW; Lee YC
    Mutat Res; 2006 Feb; 594(1-2):181-8. PubMed ID: 16318864
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TP53 codon 72 polymorphism in oral squamous cell carcinoma.
    Drummond SN; De Marco L; Pordeus Ide A; Barbosa AA; Gomez RS
    Anticancer Res; 2002; 22(6A):3379-81. PubMed ID: 12530090
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Associations between polymorphisms in DNA repair genes and TP53 mutations in non-small cell lung cancer.
    Cho S; Kim MJ; Choi YY; Yoo SS; Lee WK; Lee EJ; Jang EJ; Bae EY; Jin G; Jeon HS; Lee SY; Cha SI; Park TI; Kim CH; Park JY
    Lung Cancer; 2011 Jul; 73(1):25-31. PubMed ID: 21129811
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p53 codon 72 polymorphism associated with risk of human papillomavirus-associated squamous cell carcinoma of the oropharynx in never-smokers.
    Ji X; Neumann AS; Sturgis EM; Adler-Storthz K; Dahlstrom KR; Schiller JT; Wei Q; Li G
    Carcinogenesis; 2008 Apr; 29(4):875-9. PubMed ID: 18258602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.